Risk Distribution & Opportunity Costs in Entrepreneurship
Risk Distribution In WIRED, "One Startup’s Struggle to Survive the Silicon Valley Gold Rush"…
biotech
There are 59 articles under this tag
Private vs Public: Privacy in Trials
There was quite a ruckus in the cancer drug development community when Memorial Sloan Kettering Cancer…
Biotechnology & Madison High Schools
At the Biotech in WI Meetup this week, we learned about the Biotechnology elective…
R&D Scientists: Welcome to Your Contract
This tweet recently caught my eye. (I'm assuming pharma here is drug related, including…
Partnering Tidbits from Turin
I've escaped the cube farm long enough to share a few thoughts from BIO-Europe…
Personal Risk & Social Media in Pharma/Biotech
Benefit: Something that promotes or enhances well-being Risk: the possibility of suffering harm or…
Is Biotech Venture Capital Dying?
This post was inspired by the Xconomy story Wisconsin 2013 VC Activity Drops, Shifts…
Social Media & Cancer Drugs: Conversation, not Promotion
*This post was originally posted at Xconomy.* (Updated to include Lilly COI in table based…
2013 in the Rearview
I attribute my habit of testing out social media to the family lore that…
Early Stage Biotech Investing in Wisconsin: Hot or Not?
In this post, I want to look at funding, particularly via angel investing, of…
Load More